Fetal Down syndrome screening models for developing countries; Part II: Cost-benefit analysis
© 2019 The Author(s). Background: To identify the most cost-beneficial model as a national policy of screening and diagnosis of fetal Down syndrome (DS) in developing countries. Methods: Cost-benefit analysis (CBA) was performed based on the effectiveness and probabilities derived from a large prosp...
Saved in:
Main Authors: | Chanane Wanapirak, Piyaluk Buddhawongsa, Woraluck Himakalasa, Auttapan Sarnwong, Theera Tongsong |
---|---|
Format: | Journal |
Published: |
2020
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85075721483&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/67944 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Fetal Down syndrome screening models for developing countries; Part I: Performance of Maternal Serum Screening
by: Chanane Wanapirak, et al.
Published: (2020) -
Strong impact of ethnicity on effectiveness of the first trimester maternal serum screen of fetal Down syndrome
by: Thitikarn Lerthiranwong, et al.
Published: (2018) -
Strong impact of ethnicity on effectiveness of the first trimester maternal serum screen of fetal Down syndrome
by: Thitikarn Lerthiranwong, et al.
Published: (2018) -
First-trimester serum biomarker screening for fetal Down syndrome as a predictor of preterm delivery: a population-based study
by: Weerawich Pornwattanakrilert, et al.
Published: (2018) -
Second-trimester maternal serum screening for fetal Down syndrome: As a screening test for hemoglobin Bart's disease: A prospective population-based study
by: Chanane Wanapirak, et al.
Published: (2018)